Evidence map›Paper›PMID 32536057›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Rosiglitazone inhibits hepatic stellate cell proliferation by regulating peroxisome proliferator-activated receptor gamma/ heme oxygenase-1 expression].

H Yang, L F Zhao, L Zhang, X H Zhang, X Q Zhang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

H YangDepartment of Infectious Diseases, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
L F ZhaoDepartment of Infectious Diseases, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
L ZhangDepartment of Infectious Diseases, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
X H ZhangDepartment of Infectious Diseases, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
X Q ZhangDepartment of Infectious Diseases, First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Shanxi Medical University · CNFirst Hospital of Shanxi Medical University · CN

Funding

Foundation of Health and Family Planning Commission of Shanxi Province 201601030Foundation of Research Projects of Key Programs in Shanxi Province 201803D421064
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hypoglycemic AgentsPPAR gammaRosiglitazoneCell ProliferationHeme Oxygenase-1Hepatic Stellate CellsHeme Oxygenase-1Hypoglycemic AgentsPPAR gammaRosiglitazoneHeme oxygenase-1Hepatic stellate cellsPeroxisome proliferator-activated receptor γRosiglitazone

Identifiers

PMID32536057
PMCPMC12769833
OpenAlexW3035322514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.